2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Pharmacokinetic profile of ONO-2160/CD (levodopa prodrug/carbidopa) in animal and human

M. Nomoto, M. Nagai, N. Nishikawa, K. Yano, Y. Kagamiishi, M. Akisada, S. Saito, M. Yuba, T. Koyanagi, A. Takeda (Tohon Ehime, Japan)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Phenomenology of idiopathic adult-onset truncal dystonia

D.J. Ehrlich, S.J. Frucht (New York, NY, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Physical therapy, a third wheel in the management of Parkinson’s disease

M.V. Alvarez, M. Rodriguez (San Antonio, TX, USA)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Physiological and biomechanical responses of people with Parkinson’s during Zumba Gold®: Effects of dance styles and number of sessions

A. Delextrat, J. Bateman, P. Esser, N. Targen, H. Dawes, M.A. Delextrat (Oxford, United Kingdom)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Physiotherapy can reduce the decline in functioning according to ICF framework in patients in early stage of Parkinson’s disease evolution

E.T.N. Guelfi, E. Okamoto, F.B. Tarallo, J.C. Elmauer, R.R. Fermino, V.F. Giangiardi, P. Yuki, E.P. Piemonte (São Paulo, Brazil)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Pilot study on the long lasting effectivness of an integrated tailored sensory-motor rehabilitation program associated with BoNTA in cervical dystonia

A. Castagna, M. Ramella, A. Crippa, L. Sciumè, G. Giacobbi, C. Corrini, D. Anastasi, A. Montesano (Milano, Italy)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Pisa syndrome in Parkinson’s disease: A mobile orfixed deformity?

E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva, F.K. Shermukhamedova (Taskent, Uzbekistan)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Pre-pulse inhibition of blink reflex in cervical dystonia

M. Kiziltan, O. Öztürk, A. Gündüz (Istanbul, Turkey)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?

T. Falk, M.J. Bartlett, T. Ye, L.B. Lazarus, M.L. Heien, S.L. Cowen, S.J. Sherman (Tucson, AZ, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Predicting medication reduction in Parkinson’s disease patients after deep brain stimulation

S.A. Dodwell, C.E. Ashton, D.K. Simon, D. Tarsy, E. Papavassiliou, R. Alterman, L. Shih (Boston, MA, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2